EFX vs EXAS Stock Comparison

EFX currently leads EXAS in this stock comparison, with AIQ scores of 57 vs 46. The clearest difference is value, while EXAS has the stronger risk resilience profile.

Market data as of Oct 21, 2026 market close· AIQ score gap 11 points
EFX
Industrials
vs
EXAS
Healthcare
EFX
Equifax Inc.
Leads
Price
$176
Day move
-0.55%
AIQ Score
57/100
Best edge
Value
Sector
Industrials
EXAS
Exact Sciences Corporation
Price
$105
Day move
-
AIQ Score
46/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between EFX and EXAS?

EFX leads the current stock comparison as Equifax Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Equifax Inc. vs Exact Sciences Corporation

Data as of Oct 21, 2026· market close· Cross-sector · Industrials vs Healthcare · both in Life Sciences / Tools / CRO· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 5/10

EFX leads

EFX leads by 11 AIQ points, primarily on Value, having only recently taken the lead back from EXAS.

Fragile: 4 of 6 evidence groups support EFX, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Reversed
EFX

Equifax Inc.

Leads
AIQ Score
57/100
AIQ Edge Score
7/10
EXAS

Exact Sciences Corporation

AIQ Score
46/100
AIQ Edge Score
3/10

The Algovestiq AIQ Score currently favors EFX over EXAS, 57 versus 46 as of Oct 21, 2026. EFX's advantage is driven primarily by stronger value, while EXAS holds the stronger risk resilience profile. EFX also shows the stronger technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor EFX today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. EFX lead: Reversed — EXAS led by 6 AIQ points 30 sessions ago; EFX now leads by 11.

Compare Equifax Inc. and Exact Sciences Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

EFX
-31.5%
EXAS
+10.5%

Total return comparison

Growth of $10,000, distributions reinvested

EFX $6,849 · EXAS $11,050

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare EFX and EXAS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

EFX advantage
0
EXAS advantage
  • Risk Resilience36 vs 67
    EXAS +31
  • Value53 vs 37
    EFX +16
  • Quality46 vs 44
    Even

4 of 6 evidence groups favor EFX. EFX’s edge is concentrated in value; EXAS keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.

EFX+4 AIQ

Largest factor move: Momentum +17

New signals

  • BB Upper Band Breach — bearish, volatility, short horizon
EXAS0 AIQ

No factor moved materially.

No signal started or stopped since the prior session.

EFX's lead widened by 4 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — EFX and EXAS both carry a full feed there.

The central trade-off

EFX (Equifax Inc.): the stronger current systematic profile, led by value.

EXAS (Exact Sciences Corporation): the counter-case, on risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

EFX

EFX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

EFX

EFX on combined revenue and EPS growth.

Value

EFX

EFX on the peer-relative Value factor, by 16 points.

Momentum

Even

The two are level on Momentum.

Lower downside

EXAS

EXAS on Risk Resilience, by 31 points.

Analyst upside

EFX

EFX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureEFXEXASNote
Implied upside to target+14.1%+0.1%EFX has more room
Target dispersion+48.4%0%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering131Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor EFX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEFX57 vs 46
FundamentalsEFXon balancerevenue growth 3.1% vs 3.2%; EPS growth 8.4% vs -3.5%; TTM ROE 15% vs -8.5%; gross margin 44.4% vs 69.7%; operating margin 17.9% vs -6.2% — EFX takes 3 of 4 decided legs, not all of them
ValuationEFXValue 53 vs 37
TechnicalsEXASPrice vs 50-day 5.1% vs 1.8%; vs 200-day -1.1% vs 41.3%
Risk ResilienceEXASRisk Resilience 36 vs 67
Analyst expectationsEFXTarget upside 14.1% vs 0.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of EFX and EXAS and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 11 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EFX.

How the comparison changed

120 daily snapshots · Jun 21 – Oct 20

EFX lead: Reversed — EXAS led by 6 AIQ points 30 sessions ago; EFX now leads by 11.

Jun 21EFX leads above the line · EXAS leads belowOct 20
Today
EFX +11
57 vs 46
7 sessions ago
EFX +6
52 vs 46
30 sessions ago
EXAS +6
40 vs 46
90 sessions ago
EFX +1
47 vs 46

The lead changed hands once in this window, most recently on Sep 4 when EXAS moved ahead of EFX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

EFXConflicted

2 bullish / 3 bearish, conflicted

Only EFX

  • Death Cross Active — bearish, trend, long horizon (6.87%)
  • BB Upper Band Breach — bearish, volatility, short horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • MACD Bullish Crossover — bullish, momentum, short horizon
EXAS

No active signals

No signal that the other name lacks.

EFX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

EFXDivergence

Price is down while the AIQ Score moved up 4 points over the same session — price and model disagree (price -0.55%, AIQ +4 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1EXAS closes the Value gap — currently 16 points behind, the largest single contributor to EFX's edge.
  2. 2EXAS generates a confirmed bullish trend signal it does not currently carry, such as Golden Cross Active or MACD Bullish Crossover.
  3. 3EFX's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

EFX leads on balance
MetricEFXEXAS
Revenue growth (YoY)3.1%3.2%
EPS growth (YoY)8.4%-3.5%
Gross margin44.4%69.7%
Operating margin17.9%-6.2%
Return on equity (TTM)15%-8.5%
Debt to equity1.251.05

Performance

Split across windows
MetricEFXEXAS
1 week (5 sessions)10.8%1.3%
1 month (20 sessions)10.5%1.4%
3 months (63 sessions)3.6%3.2%
6 months (126 sessions)-8.3%100.3%
Year to date-18.6%3.3%
1 year (252 sessions)-22.3%133.5%

Technicals

EXAS has the stronger structure
MetricEFXEXAS
RSI (14)78.674.1
ADX (14)28.942.9
Price vs 50-day5.1%1.8%
Price vs 200-day-1.1%41.3%
Volatility (1M, annualized)56.2%4.2%

Risk

EXAS is the more resilient
MetricEFXEXAS
Beta0.57-0.22
Sharpe ratio-0.513.17
Sortino ratio-0.712.67
Max drawdown-41.3%-5%
Current drawdown-24.5%0%
Annualized volatility40.7%43.5%
Value at risk (95%)-4.3%-1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, EFX or EXAS?

On the Algovestiq AIQ Score, EFX is the stronger of the two as of Oct 21, 2026, scoring 57 against EXAS's 46. The edge comes from value. EXAS is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is EFX or EXAS the better buy right now?

EFX carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor EFX over EXAS?

The composite weights Quality, Value, Momentum and Risk Resilience. EXAS leads Risk Resilience by 31 points; EFX leads Value by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, EFX or EXAS?

Analyst price targets imply +14.1% upside for EFX and +0.1% for EXAS, so the Street currently favors EFX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, EFX or EXAS?

EFX is the better-valued of the two on the peer-relative Value factor. EFX on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, EFX or EXAS?

EFX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, EFX or EXAS?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, EFX or EXAS?

EXAS is the more resilient of the two, so the other name carries the higher downside risk. EXAS on Risk Resilience, by 31 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is EFX more profitable than EXAS?

The profitability evidence is mixed: gross margin 44.4% vs 69.7%; operating margin 17.9% vs -6.2%; ttm roe 15% vs -8.5%. EFX leads on two measures and EXAS on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is EFX's lead over EXAS getting stronger or weaker?

EFX lead: Reversed — EXAS led by 6 AIQ points 30 sessions ago; EFX now leads by 11. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands once in that window, most recently on 2026-09-04, when EXAS moved ahead of EFX.

What would change the EFX vs EXAS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: EXAS closes the Value gap — currently 16 points behind, the largest single contributor to EFX's edge; EXAS generates a confirmed bullish trend signal it does not currently carry, such as Golden Cross Active or MACD Bullish Crossover; EFX's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about EFX and EXAS?

EFX: 2 bullish / 3 bearish, conflicted. EXAS: No active signals. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on EFX is Death Cross Active (bearish, long horizon).

Compare EFX and EXAS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.